Last week, two bearish analysts finally threw in the towel on Tesla, and the stock market has not stopped running. The stock hit another $ 381 this week, up 24%, expanding its 2020 earnings to around 380%. Shares broke the $ 2,000 barrier on Thursday and, of course, rose again …
Read More »
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
Shares of Momenta Pharmaceuticals Inc. MNTA, + 69.40% 69% shot to record highs in prime trade Wednesday, after biotechnology company announced agreement with Johnson & Johnson JNJ, + 0.63% in a deal valued at $ 6.5 billion. Under the terms of the deal, J&J will pay $ 52.50 for each …
Read More »
States are asking for about $ 26.4 billion from major players in pharmaceutical industry to help pay for damages caused by the opioid crisis, people familiar with the matter said, the latest question in years of litigation that companies are trying to responsible for widespread drug addiction. The current talks …
Read More »
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »